| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.530 | 24.169 | 33.681 | - | - | - | - | - | - | - |
| Total Income - EUR | 11.530 | 24.169 | 33.681 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 8.664 | 10.549 | 13.318 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 2.867 | 13.620 | 20.363 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 2.683 | 12.170 | 19.353 | - | - | - | - | - | - | - |
| Employees | 0 | 0 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Bioimpact Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.362 | 2.338 | 2.298 | - | - | - | - | - | - | - |
| Current Assets | 34.621 | 53.378 | 85.435 | - | - | - | - | - | - | - |
| Inventories | 4.261 | -108 | -106 | - | - | - | - | - | - | - |
| Receivables | 7.332 | 29.827 | 60.500 | - | - | - | - | - | - | - |
| Cash | 23.028 | 23.659 | 25.041 | - | - | - | - | - | - | - |
| Shareholders Funds | 23.513 | 35.443 | 54.196 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Debts | 13.470 | 20.273 | 33.538 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4617 - 4617" | |||||||||
| CAEN Financial Year |
4617
|
|||||||||
Comments - Bioimpact Impex Srl